As your therapy operations scale from early-phase clinical trials to larger
populations in late-stage trials and commercialization, your supply chain
complexity—and risk—increases. Anticipating common setbacks and actively
planning for their solution requires a specialized and collaborative approach with
your supply chain logistics partner.
Keep these key considerations top of mind as you evaluate whether potential
partners have the experience, expertise and relationships required for the
successful transport and delivery of your cell and gene therapy.